The American Journal of Medicine
Volume 120, Issue 7 , Pages 589-590 , July 2007

Vexing Vesicles

  • Rashid M. Rashid, MD, PhD

      Affiliations

    • Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston
    • Corresponding Author InformationRequests for reprints should be addressed to Rashid Rashid, BS, Loyola University, MD PhD Department, 2160 South First Avenue, Bldg 120, Office of the Dean, John Lee, 4th Floor, Maywood, IL 60153.
    • ,
  • Wajeeh Salah, MD

      Affiliations

    • The Morzak Clinic, Carolina, PR
    • ,
  • Edward J. Keuer, MD

      Affiliations

    • Department of Internal Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio
    • Department of Dermatology, Loyola University Medical Center, Maywood, Ill.

References 

  1. Magina S, Barros MA, Ferreira JA, Mesquita-Guimaraes J. Atopy, nickel sensitivity, occupation, and clinical patterns in different types of hand dermatitis. Am J Contact Dermat. 2003;14:63–68
  2. Meding B, Swanbeck G. Epidemiology of different types of hand eczema in an industrial city. Acta Derm Venereol. 1989;69:227–233
  3. Lehucher-Michel MP, Koeppel MC, Lanteaume A, Sayag J. Dyshidrotic eczema and occupation: a descriptive study. Contact Dermatitis. 2000;43:200–205
  4. Pitche P, Boukari M, Tchangai-Walla K. Factors associated with palmoplantar or plantar pompholyx: a case-control study. Ann Dermatol Venereol. 2006;133:139–143
  5. Jain VK, Aggarwal K, Passi S, Gupta S. Role of contact allergens in pompholyx. J Dermatol. 2004;31:188–193
  6. Fisher AA. Possible role of diet in pompholyx and nickel dermatitis (A critical survey). Cutis. 1978;22:416–417
  7. Iannaccone S, Sferrazza B, Quattrini A. Pompholyx (vesicular eczema) after i.v. immunoglobulin therapy for neurologic disease. Neurology. 1999;53:1154–1155
  8. Young PK, Ruggeri SY, Galbraith S, Drolet BA. Vesicular eczema after intravenous immunoglobulin therapy for treatment of Stevens-Johnson syndrome. Arch Dermatol. 2006;142:247–248
  9. Chen JJ, Liang YH, Zhou FS, et al. The gene for a rare autosomal dominant form of pompholyx maps to chromosome 18q22.1-18q22.3. J Invest Dermatol. 2006;126:300–304
  10. Polderman MC, Govaert JC, le Cessie S, Pavel S. A double-blind placebo-controlled trial of UVA-1 in the treatment of dyshidrotic eczema. Clin Exp Dermatol. 2003;28:584–587
  11. Swartling C, Naver H, Lindberg M, Anveden I. Treatment of dyshidrotic hand dermatitis with intradermal botulinum toxin. J Am Acad Dermatol. 2002;47:667–671
  12. Schnopp C, Remling R, Mohrenschlager M, et al. Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial. J Am Acad Dermatol. 2002;46:73–77
  13. Stambaugh MD, DeNittis AS, Wallner PE, Heymann WR. Complete remission of refractory dyshidrotic eczema with the use of radiation therapy. Cutis. 2000;65:211–214
  14. Lindelof B, Wrangsjo K, Liden S. A double-blind study of Grenz ray therapy in chronic eczema of the hands. Br J Dermatol. 1987;117:77–80
  15. Cartwright PH, Rowell NR. Comparison of Grenz rays versus placebo in the treatment of chronic hand eczema. Br J Dermatol. 1987;117:73–76
  16. Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for the use of topical glucocorticosteroids. J Am Acad Dermatol. 1996;35:615–619
  17. Veien NK, Menne T. Treatment of hand eczema. Skin Therapy Lett. 2003;8:4–7

 Parwathi “Uma” Paniker, MD, Section Editor

PII: S0002-9343(07)00273-2

doi: 10.1016/j.amjmed.2007.03.012

The American Journal of Medicine
Volume 120, Issue 7 , Pages 589-590 , July 2007

Article Tools

* Image Usage & Resolution